164 related articles for article (PubMed ID: 8519640)
1. Biology and pharmacology of thiopurines.
Aarbakke J
Pediatr Hematol Oncol; 1995; 12(5):511-9. PubMed ID: 8519640
[No Abstract] [Full Text] [Related]
2. Thiopurine biology and pharmacology.
Aarbakke J; Janka-Schaub G; Elion GB
Trends Pharmacol Sci; 1997 Jan; 18(1):3-7. PubMed ID: 9114722
[No Abstract] [Full Text] [Related]
3. Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.
Hawwa AF; Millership JS; Collier PS; Vandenbroeck K; McCarthy A; Dempsey S; Cairns C; Collins J; Rodgers C; McElnay JC
Br J Clin Pharmacol; 2008 Oct; 66(4):517-28. PubMed ID: 18662289
[TBL] [Abstract][Full Text] [Related]
4. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.
Relling MV; Gardner EE; Sandborn WJ; Schmiegelow K; Pui CH; Yee SW; Stein CM; Carrillo M; Evans WE; Klein TE;
Clin Pharmacol Ther; 2011 Mar; 89(3):387-91. PubMed ID: 21270794
[TBL] [Abstract][Full Text] [Related]
5. Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism.
Lennard L; Lilleyman JS
Ther Drug Monit; 1996 Aug; 18(4):328-34. PubMed ID: 8857546
[TBL] [Abstract][Full Text] [Related]
6. Optimizing treatment with thioguanine derivatives in inflammatory bowel disease.
Louis E; Belaiche J
Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):37-46. PubMed ID: 12617881
[TBL] [Abstract][Full Text] [Related]
7. 6-MP metabolite levels: a potential guide to Crohn's disease therapy.
Sandborn WJ
Gastroenterology; 1997 Aug; 113(2):690-2. PubMed ID: 9247497
[No Abstract] [Full Text] [Related]
8. Recent advances in the pharmacogenomics of thiopurine methyltransferase.
Coulthard SA; Hall AG
Pharmacogenomics J; 2001; 1(4):254-61. PubMed ID: 11908768
[TBL] [Abstract][Full Text] [Related]
9. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.
Pettersson B; Almer S; Albertioni F; Söderhäll S; Peterson C
Ther Drug Monit; 2002 Jun; 24(3):351-8. PubMed ID: 12021625
[TBL] [Abstract][Full Text] [Related]
10. Next steps on the thiopurine methyltransferase 6-thioguanine nucleotide pathway.
Colletti RB
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):282-3. PubMed ID: 16954947
[No Abstract] [Full Text] [Related]
11. Chemical action and pharmacology of methotrexate, azathioprine and cyclophosphamide in man.
Bertino JR
Arthritis Rheum; 1973; 16(1):79-83. PubMed ID: 4540289
[No Abstract] [Full Text] [Related]
12. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.
Lennard L; Welch JC; Lilleyman JS
Br J Clin Pharmacol; 1997 Nov; 44(5):455-61. PubMed ID: 9384462
[TBL] [Abstract][Full Text] [Related]
13. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
Kiszka-Kanowitz M; Theede K; Nielsen AM
Ugeskr Laeger; 2014 May; 176(22):. PubMed ID: 25352005
[TBL] [Abstract][Full Text] [Related]
14. Human thiopurine methyltransferase: no evidence of activation by its substrates.
Stupans I; Kirlich A; McKinnon RA
Life Sci; 1998; 62(4):343-50. PubMed ID: 9450506
[TBL] [Abstract][Full Text] [Related]
15. Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations.
Lancaster DL; Lennard L; Rowland K; Vora AJ; Lilleyman JS
Br J Haematol; 1998 Jul; 102(2):439-43. PubMed ID: 9695957
[TBL] [Abstract][Full Text] [Related]
16. Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells.
Lennard L; Maddocks JL
J Pharm Pharmacol; 1983 Jan; 35(1):15-8. PubMed ID: 6131958
[TBL] [Abstract][Full Text] [Related]
17. Optimizing immunomodulator therapy for inflammatory bowel disease.
Dubinsky MC
Curr Gastroenterol Rep; 2003 Dec; 5(6):506-11. PubMed ID: 14602061
[TBL] [Abstract][Full Text] [Related]
18. Skin Toxicity Due to Mercaptopurine in Maintenance Therapy Among Children With Acute Lymphoblastic Leukemia.
Higgerson K; Flatt T
J Pediatr Hematol Oncol; 2023 May; 45(4):e514-e517. PubMed ID: 37027323
[TBL] [Abstract][Full Text] [Related]
19. 6-mercaptopurine metabolite levels in children with inflammatory bowel disease.
Gupta P; Gokhale R; Kirschner BS
J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):450-4. PubMed ID: 11698762
[TBL] [Abstract][Full Text] [Related]
20. [Research advances in pharmacogenomics of mercaptopurine].
Chen XX; Shen SH
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Sep; 19(9):1027-1033. PubMed ID: 28899477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]